Related Experiment Video
Updated: Jun 2, 2026

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
Insight into the Interaction and Inhibition of NS3 ATPase of Dengue Virus with 3'-Azido-3'-deoxythymidine:
Ayesha Tazeen1, Tanzeel Khan1, Abdus Samad1
1Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.
Abstract:
The NS3 protein of dengue virus (DENV) is highly conserved and plays a vital role in replication, and thus it is considered as a potential antiviral target. The current study was carried out to observe interactions between the NS3 protein of DENV-4 and 3'-azido-3'-deoxythymidine (AZT-TP) using biophysical studies and ATPase inhibition assays, and further complemented it with in silico approaches. Fluorescence and time-resolved studies showed significant static quenching of NS3 fluorophores. Surface plasmon resonance (SPR) studies showed strong binding affinity with a significant pharmacodynamics rate, i.e., higher kinetic rate of association (k a) and lower dissociation rate constant (Kd). Isothermal titration calorimetry (ITC) measurements revealed strong and spontaneous binding between NS3 and AZT-TP with feasible thermodynamic parameters. The ATPase inhibition assay showed a decrease in NS3 ATPase activities in a dose-dependent manner, indicating the inhibitory potential of AZT-TP. Molecular docking showed significant binding (-8.0 kcal/mol) with the conserved residues involved in NS3 helicase/ATPase activities. Molecular dynamics (MD) simulation studies showed no major conformational changes in the NS3 and AZT-TP complex, and it was well-anchored at its binding position with nearly a linear trajectory up to 200 ns. Total Gibbs free energy and contribution of different interactions calculated using MMPB-(GB)-SA complemented the biophysical and docking results. The study suggests that there might be a direct binding between AZT-TP and residues involved in the ATPase activities and thus provides promising data to explore the future prospects of AZT-TP as an NS3 inhibitor for antiviral development.

